“The INGENIO™ device enables physicians to treat pacemaker patients with an advanced and comprehensive set of therapies,” said Dr. George Predeteanu, the Cardiologist who implanted the first device at Hurley Medical Center. The INGENIO™ pacemaker’s minute ventilation (MV) sensor is easy to optimize and will provide needed therapy for patients with chronotropic incompetence (CI) to help them feel less fatigued during physical activity,” adds Dr. Predeteanu.
"Having access to my patient’s respiratory rates, as needed, will help me proactively manage their heart failure symptoms and make any medical changes necessary before their symptoms get worse. The goal is to keep patients out of the hospital," said Dr. Samir Elian, Interventional Cardiologist. Dr. Elian’s patient received the pacemaker at Hurley on May 15, 2012.
INGENIO™ pacemakers feature RightRate™ technology. RightRate™
The INGENIO™ pacemaker will also have the capacity to transmit implantable cardiac device data from the device to physicians and other healthcare providers. Boston Scientific’s new LATITUDE NXT® Remote Patient Management system, currently under review by the FDA, will let physicians conduct remote follow-ups of these device patients to monitor specific device information and heart health status. The system will also detect clinical events between scheduled visits and send relevant data directly to a secure website, which can be accessed by physicians. This wireless technology will allow patients to transmit data to physicians from most locations in North America without the need for landline-based technology.
Media: For interviews, please contact Ilene Cantor, Interim Administrator, Marketing, Community and Public Relations at Hurley Medical Center at email@example.com or 810-262-7164.